Birth Weight and Preterm Birth in Babies of Pregnant Women With Major Depression in Relation to Treatment With Antidepressants
暂无分享,去创建一个
F. Uguz | Mine Şahingöz | B. Annagur | A. Annagur | Ç. Karşıdağ | G. Yuksel | Erdem Onder Sonmez | B. B. Annagur
[1] M. Walsh,et al. Fanaroff and Martin's neonatal-perinatal medicine : , 2015 .
[2] A. Gilbert,et al. Neonatal Outcomes After Late-Gestation Exposure to Selective Serotonin Reuptake Inhibitors , 2012, Journal of clinical psychopharmacology.
[3] G. Koren,et al. Antidepressant use during pregnancy: the benefit-risk ratio. , 2012, American journal of obstetrics and gynecology.
[4] F. Uguz,et al. Is hyperemesis gravidarum associated with mood, anxiety and personality disorders: a case-control study. , 2012, General hospital psychiatry.
[5] G. Koren,et al. Pregnancy Outcome After Exposure to Antidepressants and the Role of Maternal Depression: Results From the Norwegian Mother and Child Cohort Study , 2012, Journal of clinical psychopharmacology.
[6] D. Davalos,et al. Untreated prenatal maternal depression and the potential risks to offspring: a review , 2012, Archives of Women's Mental Health.
[7] Francesc Botet,et al. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose. , 2011, Journal of affective disorders.
[8] M. Black,et al. Maternal depression and early childhood growth in developing countries: systematic review and meta-analysis. , 2011, Bulletin of the World Health Organization.
[9] Tram Nguyen,et al. Antidepressants in Pregnancy: a Systematic Review , 2010, The Australian and New Zealand journal of psychiatry.
[10] Satish Iyengar,et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. , 2010, Archives of general psychiatry.
[11] H. Malm,et al. Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs). , 2010, Reproductive toxicology.
[12] A. Buist,et al. Neonatal Growth Outcomes at Birth and one Month Postpartum Following In Utero Exposure to Antidepressant Medication , 2010, The Australian and New Zealand journal of psychiatry.
[13] F. Uguz,et al. Is pregnancy associated with mood and anxiety disorders? A cross-sectional study. , 2010, General hospital psychiatry.
[14] Lisa M Bodnar,et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. , 2009, The American journal of psychiatry.
[15] P. Rucci,et al. Axis I psychopathology and functional impairment at the third month of pregnancy: Results from the Perinatal Depression-Research and Screening Unit (PND-ReScU) study. , 2008, The Journal of clinical psychiatry.
[16] Truls Østbye,et al. Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. , 2008, JAMA.
[17] R. Platt,et al. Use of antidepressant medications during pregnancy: a multisite study. , 2008, American journal of obstetrics and gynecology.
[18] V. Grech,et al. Antenatal psychiatric morbidity in Maltese women. , 2007, General hospital psychiatry.
[19] J. Mintz,et al. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. , 2007, The American journal of psychiatry.
[20] Ariel J. Jaffa,et al. Neurodevelopmental Outcome of Children With Intrauterine Growth Retardation: A Longitudinal, 10-Year Prospective Study , 2007, Journal of child neurology.
[21] W. Holzgreve,et al. Depression and anxiety during pregnancy: A risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature , 2007, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[22] T. Einarson,et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. , 2006, The Journal of clinical psychiatry.
[23] C. Hertzman,et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. , 2006, Archives of general psychiatry.
[24] M. Bixo,et al. Depression and anxiety during pregnancy and six months postpartum: a follow‐up study , 2006, Acta obstetricia et gynecologica Scandinavica.
[25] N. Kaciroti,et al. Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis , 2005, Journal of Perinatology.
[26] M. Bixo,et al. Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. , 2003, American journal of obstetrics and gynecology.
[27] M. Kramer,et al. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. , 2000, JAMA.
[28] L. Gottwald,et al. [Intrauterine growth restriction]. , 2005, Przeglad lekarski.
[29] Sho Tin Chen,et al. National Institute of Mental Health , 2020, Definitions.
[30] J. C. Ingram. On the Obstetric Management of Prematurity , 1937 .